You are here
What Is Known About COVID-19 and Abnormal Blood Clotting
July 3, 2020
Dr. Jeffrey Laurence, a professor of medicine in the Division of Hematology and Medical Oncology at Weill Cornell Medicine and a hematology and oncology specialist at NewYork-Presbyterian/Weill Cornell Medical Center, and his colleagues authored a paper in Translational Research in early April that sounded the alarm about abnormal blood clotting—which prevents blood flow—in severe COVID-19 cases. He answered questions about the phenomenon and how he and his Weill Cornell Medicine colleagues are continuing to study treatments for blood clotting in these cases.